Trial intelligence / Profile preview

Hypertonic saline plus furosemide for edema in ICU patients

IRCT20191115045446N1Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of hypertonic saline and furosemide in edema, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Urine volume, Level of edema and 1 more. Started Jan 2020; status: completed.

02

Drugs

hypertonic salinefurosemide
03

Conditions

edema

Beyond the preview

Go deeper on IRCT20191115045446N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20191115045446N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call